Asklepion Pharmaceuticals is a biopharmaceutical company specializing in rare pediatric diseases. It focuses on the discovery, development, and commercialization of pharmaceutical products for acute lung injury induced by cardiopulmonary bypass and acute sickle cell crisis.
Type | Private | |
Founded | 2006 | |
HQ | Baltimore, MD, US | Map |
Website | asklepionpharm.com |
Employees (est.) (Feb 2021) | 7 | (-12%) |
Cybersecurity rating | A | More |
When was Asklepion Pharmaceuticals founded?
Asklepion Pharmaceuticals was founded in 2006.
Who are Asklepion Pharmaceuticals key executives?
Asklepion Pharmaceuticals's key executives are Gary Pasternack, Jeff Courtney and Gurdyal Kalsi.
How many employees does Asklepion Pharmaceuticals have?
Asklepion Pharmaceuticals has 7 employees.
Who are Asklepion Pharmaceuticals competitors?
Competitors of Asklepion Pharmaceuticals include Biogen, Inovio Pharmaceuticals and Athersys.
Where is Asklepion Pharmaceuticals headquarters?
Asklepion Pharmaceuticals headquarters is located at 729 E Pratt St #360, Baltimore.
Where are Asklepion Pharmaceuticals offices?
Asklepion Pharmaceuticals has an office in Baltimore.
How many offices does Asklepion Pharmaceuticals have?
Asklepion Pharmaceuticals has 1 office.
Receive alerts for 300+ data fields across thousands of companies